n.a. (CHTP)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Biotech Stock Mailbag: Sarepta, Chelsea, IPO Fever

Biotech Stock Mailbag: Sarepta, Chelsea, IPO Fever

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)

Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)

In a bubbly year for the biotech sector, these five stocks stand out over the rest.

4 Stocks Under $10 Making Big Moves

4 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Chelsea Therapeutics Announces Presentation Of Northera(TM) (droxidopa) Study 306 Data At The American Academy Of Neurology Annual Meeting

Chelsea Therapeutics Announces Presentation Of Northera(TM) (droxidopa) Study 306 Data At The American Academy Of Neurology Annual Meeting

Results Highlighted by AAN in Emerging Science Program and as Breaking News

5 Stocks Ready to Break Out

5 Stocks Ready to Break Out

These stocks look poised to break out and trade higher from current levels.

4 Health Care Stocks Under $10 Spiking Higher

4 Health Care Stocks Under $10 Spiking Higher

Stocks that are making large moves like these are favorites among short-term traders.

3 Stocks Under $5 Moving Higher

3 Stocks Under $5 Moving Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Branham Law, LLP Announces An Investigation Of Chelsea Therapeutics International, Ltd. For Possible Securities Law Violations

Branham Law, LLP Announces An Investigation Of Chelsea Therapeutics International, Ltd. For Possible Securities Law Violations

Branham Law, LLP announces an investigation has been launched into the actions of the officers and directors of Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics' Management Presents At 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript)

Chelsea Therapeutics' Management Presents At 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript)

Chelsea Therapeutics' Management Presents at 2012 Wedbush PacGrow Life Sciences Management Access Conference (Transcript)

Biotech Stock Mailbag: Amarin or Arena Takeout?

Biotech Stock Mailbag: Amarin or Arena Takeout?

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline

Chelsea Therapeutics International Lead Plaintiff Deadline - June 4, 2012: Levi & Korsinsky Reminds Investors With Losses On Their Investment In Chelsea Therapeutics International Of Class Action And The Lead Plaintiff Deadline

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Western District of North Carolina on behalf of investors who purchased Chelsea Therapeutics...

Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript)

Chelsea Therapeutics' CEO Discusses Completion Of EoR Meeting With FDA For Northera Capsules NDA (Transcript)

Chelsea Therapeutics' CEO Discusses Completion of EoR Meeting with FDA for Northera Capsules NDA (Transcript)

Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position

Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Western District of North Carolina on behalf of investors who purchased Chelsea Therapeutics...

Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd.

Chelsea Therapeutics International Shareholder Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of Chelsea Therapeutics International, Ltd.

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, and the securities litigation firm of Powers Taylor, LLP announce that the firms are...

Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position

Upcoming Deadline: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Chelsea Therapeutics International Ltd. Of Class Action Lawsuit And The Deadline Of June 4, 2012 To Seek A Lead Plaintiff Position

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Western District of North Carolina on behalf of investors who purchased Chelsea Therapeutics...

Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript)

Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter From Food And Drug Administration For Northera(TM) (droxidopa) Capsules (Transcript)

Chelsea Therapeutics' CEO Discusses Chelsea Therapeutics Receives Complete Response Letter from Food and Drug Administration for Northera(TM) (droxidopa) Capsules (Transcript)

Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest

Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest

Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

The Next Big Thing in Biotech: FDA Decisions

The Next Big Thing in Biotech: FDA Decisions

Senior columnist Adam Feuerstein explains the importance of three FDA drug approval decisions.

Biotech Stock Chat: Recap

Biotech Stock Chat: Recap

TheStreet's biotech columnist Adam Feuerstein is holding a live, interactive discussion about biotech and biotech stock investing.